Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose rosuvastatin vs high-dose rosuvastatin + ezetimibe in acute ischemic stroke
KCT0007204Phase 4Recruiting
- Sponsor
- Yuhan
- Start
- Sep 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin, ezetimibe in ischemic stroke, hyperlipidemia, sponsored by Yuhan. Started Sep 2022; status: recruiting.
02
Drugs
rosuvastatinezetimibe
03
Conditions
ischemic strokehyperlipidemia
Beyond the preview
Go deeper on KCT0007204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0007204.